Malpractice News: Possible Vytorin Link to Cancer

Malpractice News: In August 2008, the FDA released a communication regarding the cholesterol drug Vytorin and a report that the drug may put users at an increased risk of developing cancer. The statement discussed the results of a clinical trial that noted higher rates of cancer in patients taking the drug, but cautioned patients not to stop taking the drug.

Vytorin is a combination of two drugs: a statin drug, which reduces the levels of LDL (so-called “bad” cholesterol in the blood), and a second drug which limits the amount of cholesterol absorbed through the digestive system.

The Journal of the American College of Cardiology also published an August 2008 report on statin studies on over 90,000 patients, where the researchers concluded the statin users in the study were at no increased risk to develop cancer than the participants who received placebos.

Our medical malpractice lawyers are here to help you.

If you have been harmed by a health professional, please complete the form below for a free medical malpractice lawsuit review. A representative of our firm will be in touch shortly.

Click To Talk To Us Online

see also:

Malpractice News: Vytorin and Zetia Malpractice News: Vytorin and Zetia marketing lawsuit filed January 08
Malpractice News: Makers of Vytorin and Zetia marketing lawsuit filed

Malpractice News: Medpedia Malpractice News: Read about Medpedia, a new medical information site
Malpractice News: Medpedia is an source for medical information online

W&L Malpractice News Medical Malpractice Lawyer Comments on Medical Errors in the News
Cases of malpractice hit newspaper--our attorneys investigate lawsuits